Trial Profile
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Flexibly-Dosed Extended-Release Paliperidone as Adjunctive Therapy to Mood Stabilizers in the Treatment of Acute Manic and Mixed Episodes Associated with Bipolar I Disorder
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 26 May 2011
Price :
$35
*
At a glance
- Drugs Paliperidone (Primary) ; Mood stabilisers
- Indications Bipolar I disorders
- Focus Therapeutic Use
- Sponsors Janssen-Cilag
- 26 May 2011 New trial record